European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine

Personalized Medicine
Sebastian Schee Genannt HalfmannAngela Brand

Abstract

Personalized medicine (PM) is no longer an abstract healthcare approach. It has become a reality over the last years and is already successfully applied in the various medical fields. Although there are success stories of implementing PM, there are still many more opportunities to further implement and make full use of the potential of PM. We assessed the system readiness of healthcare systems in Europe to shift from the predominant 'one size fits all' healthcare approach to PM. We conclude that European healthcare systems are only partially ready for PM. Key challenges such as integration of big data, health literacy, reimbursement and regulatory issues need to be overcome in order to strengthen the implementation and uptake of PM.

References

Jan 13, 1996·BMJ : British Medical Journal·D L SackettW S Richardson
Apr 28, 2001·Trends in Molecular Medicine·B B SpearJ Huff
Dec 15, 2004·The Milbank Quarterly·Trisha GreenhalghOlivia Kyriakidou
Jul 13, 2007·Molecular Systems Biology·Joseph LoscalzoAlbert-Laszlo Barabasi
Apr 20, 2011·Circulation·Dan M RodenC Michael Stein
Jul 2, 2011·Nature Reviews. Drug Discovery·Hans-Georg EichlerBrigitte Bloechl-Daum
Jul 5, 2011·Annual Review of Genomics and Human Genetics·Isaac S Chan, Geoffrey S Ginsburg
Dec 14, 2011·Current Opinion in Biotechnology·Matthew B ScholzPatrick S G Chain
Jan 27, 2012·BMC Public Health·Kristine SørensenUNKNOWN (HLS-EU) Consortium Health Literacy Project European
Mar 1, 2012·New Biotechnology·Joshua P Cohen
Apr 24, 2012·International Journal of Epidemiology·Shah Ebrahim
Aug 1, 2012·Expert Review of Molecular Diagnostics·Shuji OginoEdward Giovannucci
Nov 13, 2012·Annual Review of Pharmacology and Toxicology·Urs A MeyerMatthias Schwab
Dec 19, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Eric FaulknerUNKNOWN Personalized Medicine Development and Reimbursement Working Group
Aug 15, 2013·BMC Medicine·Brian GodmanLars L Gustafsson
Sep 4, 2013·Nature Reviews. Genetics·Kym M BoycottAlex E MacKenzie
Nov 2, 2013·JMIR Research Protocols·Filippo CastiglioneMarc Ernst
Nov 19, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Simona FranciosoMario Angelico
Dec 24, 2013·BMC Medical Ethics·Sebastian SchleidgenGeorg Marckmann
Feb 12, 2014·Methods of Information in Medicine·E HafenA Brand
Mar 19, 2014·Journal of Oncology Practice·Jeffery C Ward
Mar 29, 2014·British Journal of Cancer·J WasonN Stallard
Jun 24, 2014·Pharmacogenomics·Geraldine PerkinsPierre Laurent-Puig
Jul 26, 2014·European Journal of Internal Medicine·Ilaria CuticaGabriella Pravettoni
Jul 30, 2014·International Journal of Cancer. Journal International Du Cancer·Paul HanlyLinda Sharp
Dec 10, 2014·Expert Review of Clinical Pharmacology·Brian GodmanLars L Gustafsson
Jan 21, 2015·JMIR Medical Informatics·Weiqi Wang, Eswar Krishnan
Mar 15, 2015·Public Health Genomics·Isabelle Budin-Ljøsne, Jennifer R Harris
Apr 7, 2015·European Journal of Public Health·Kristine SørensenUNKNOWN HLS-EU Consortium
May 1, 2015·Nature·Nicholas J Schork
Jun 27, 2015·BMC Medical Genomics·Akram AlyassDavid Meyre
Aug 1, 2015·Lancet·Denis HorganMark Lawler
Aug 27, 2015·European Heart Journal·Nick TownsendMike Rayner
Nov 12, 2015·Public Health Genomics·Simon J Hollingsworth, Andrew V Biankin
Nov 14, 2015·Public Health Genomics·Anastassia NegroukGabriella Pravettoni
May 15, 2016·International Journal of Public Health·Angela BrandKapaettu Satyamoorthy
Jun 3, 2016·BMJ : British Medical Journal·Nigel Hawkes
Aug 18, 2016·BMJ : British Medical Journal·Nigel Hawkes
Aug 18, 2016·BMJ : British Medical Journal·Courtney DavisMartin McKee
Mar 1, 2012·Personalized Medicine·Hans Lehrach, UNKNOWN IT Future of Medicine consortium
Mar 1, 2012·Personalized Medicine·Carsten Carlberg

❮ Previous
Next ❯

Citations

Sep 25, 2018·International Journal of Technology Assessment in Health Care·Lina BalaisyteMickaël Hiligsmann
Mar 23, 2018·Biomedical Reports·Ensaf M Al-HujailyMohamed Boudjelal
Apr 5, 2018·Public Health Genomics·Laura MählmannAngela Brand
May 16, 2019·Public Health Genomics·Sebastian Schee Genannt HalfmannAngela Brand

❮ Previous
Next ❯

Software Mentioned

Omics
PerMed

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advances in Experimental Medicine and Biology
Sebastian Schee Genannt HalfmannAngela Brand
Fertility and Sterility
Owen K Davis, Zev Rosenwaks
Vaccine
Lucija Tomljenovic, Christopher A Shaw
Nature Reviews. Genetics
Oswaldo TrellesRitsert C Jansen
© 2022 Meta ULC. All rights reserved